Daniel Joseph OConnell

Insider Reports History

Entity
Individual
Location
C/O Acumen Pharmaceuticals, Inc., 427 Park Street, Charlottesville, VA
Signature
/s/ Derek Meisner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniel Joseph OConnell:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Acumen Pharmaceuticals, Inc. President and CEO, Director Common Stock 502K $1.74M $3.47 Jan 19, 2024 Direct
Acumen Pharmaceuticals, Inc. President and CEO, Director Employee Stock Option (right to buy) 602K Jan 2, 2024 Direct

Insider Reports Filed by Daniel Joseph OConnell

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ABOS Acumen Pharmaceuticals, Inc. Jan 19, 2024 1 -$52.8K 4 Jan 19, 2024 President and CEO, Director
ABOS Acumen Pharmaceuticals, Inc. Jan 2, 2024 2 $0 4 Jan 4, 2024 President and CEO, Director
ABOS Acumen Pharmaceuticals, Inc. Jan 17, 2023 2 $0 4 Jan 18, 2023 President and CEO, Director
ABOS Acumen Pharmaceuticals, Inc. Jan 19, 2022 1 $0 4 Jan 21, 2022 President and CEO, Director
ABOS Acumen Pharmaceuticals, Inc. Nov 30, 2021 2 $5K 4 Dec 2, 2021 President and CEO, Director
ABOS Acumen Pharmaceuticals, Inc. Jul 6, 2021 5 -$4 4 Jul 8, 2021 President and CEO, Director
ABOS Acumen Pharmaceuticals, Inc. Jun 30, 2021 0 $0 3 Jun 30, 2021 President and CEO, Director